Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials

por Taber, Louise, Bond, T Christopher, Wang, Xuezhe, Kadakia, Aditi, Mayne, Tracy J
Publicado 2017

Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery–Associated Acute Kidney Injury

por Ayad, Sabry, Neylan, John F., Mayne, Tracy J., Gouveia, Deborah, Swaminathan, Madhav
Publicado 2020

Secular trends in opioid prescribing in the USA

por Pezalla, Edmund J, Rosen, David, Erensen, Jennifer G, Haddox, J David, Mayne, Tracy J
Publicado 2017

Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function

por Vincenti, Flavio, Kim, Jim, Gouveia, Deborah, Pelle, Gabrielle, Mayne, Tracy J., Neylan, John F.
Publicado 2020

Defining a minimal clinically meaningful difference in 12‐month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation

por Mayne, Tracy J., Nordyke, Robert J., Schold, Jesse D., Weir, Matthew R., Mohan, Sumit
Publicado 2021

Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation

por Bromberg, Jonathan S., Weir, Matthew R., Gaber, A. Osama, Yamin, Michael A., Goldberg, Itzhak D., Mayne, Tracy J., Cal, Weizhong, Cooper, Matthew
Publicado 2021